Efficacy of DMARDs and methylprednisolone treatment on the gene expression levels of HSPA5, MMD, and non-coding RNAs MALAT1, H19, miR-199a-5p, and miR-1-3p, in patients with rheumatoid arthritis
- 24 May 2022
- journal article
- research article
- Published by Elsevier in International Immunopharmacology
- Vol. 108, 108878
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Systematic Transcriptome Wide Analysis of lncRNA-miRNA InteractionsPLOS ONE, 2013
- The lncRNA Malat1 Is Dispensable for Mouse Development but Its Transcription Plays a cis-Regulatory Role in the AdultCell Reports, 2012
- A novel pathogenic role of the ER chaperone GRP78/BiP in rheumatoid arthritisJournal of Experimental Medicine, 2012
- The Unfolded Protein Response: From Stress Pathway to Homeostatic RegulationScience, 2011
- MicroRNA-146a expresses in interleukin-17 producing T cells in rheumatoid arthritis patientsBMC Musculoskeletal Disorders, 2010
- Evolution and Functions of Long Noncoding RNAsCell, 2009
- miR2Disease: a manually curated database for microRNA deregulation in human diseaseNucleic Acids Research, 2009
- Expression of microRNA‐146 in rheumatoid arthritis synovial tissueArthritis & Rheumatism, 2008
- Possible physiological role of H19 RNAMolecular Carcinogenesis, 2002
- Molecular Cloning of a Novel Macrophage Maturation-Associated Transcript Encoding a Protein with Several Potential Transmembrane DomainsBiochemical and Biophysical Research Communications, 1995